Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Renovaro Inc. - Common Stock (NQ: RENB )

1.470 UNCHANGED
Streaming Delayed Price Updated: 10:13 AM EDT, May 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 42,875
Open 1.470
Bid (Size) 1.450 (7)
Ask (Size) 1.490 (5)
Prev. Close 1.470
Today's Range 1.450 - 1.530
52wk Range 0.6601 - 5.250
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy
From Renovaro Inc
Via GlobeNewswire
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:RENB),(NASDAQ:CYTO),(NYSE:PFE),(NYSE:ABBV) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Death
Exposures Death

Performance

YTD
-53.92%
-53.92%
1 Month
-25.38%
-25.38%
3 Month
-27.23%
-27.23%
6 Month
-55.86%
-55.86%
1 Year
+95.48%
+95.48%

More News

Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
From FN Media Group LLC
Via GlobeNewswire
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
Via Benzinga
RENB Stock Earnings: Renovaro Biosciences Reported Results for Q3 2024
Via InvestorPlace
Renovaro Inc. (NASDAQ: RENB) Aims To Revolutionize Cancer Detection And Treatment Using Multi-Cancer Detection Model With Nvidia AI Chips For Leadership In Early Detection
Via News Direct
Topics Artificial Intelligence Death
Exposures Artificial Intelligence Death
Launch of Groundbreaking Cancer Detection Platform Flamingo with Nvidia AI Computing Power, Plus Plans to Acquire 100% Ownership of Cyclomics: Renovaro Inc. (Nasdaq: RENB)
Via Get News
Topics Artificial Intelligence
Exposures Artificial Intelligence
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics
From Renovaro Inc
Via GlobeNewswire
Trailblazing AI Driven Early Cancer Diagnostics and Therapeutics for Detection with Nvidia Super Computing Power; Acquiring 100% Ownership of Cyclomics; Renovaro Inc. (Nasdaq: RENB)
Via Get News
Topics Artificial Intelligence
Exposures Artificial Intelligence
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
From Renovaro Inc
Via GlobeNewswire
Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient
From Renovaro Biosciences Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Waldencast, Chemours, Trupanion, and Renovaro and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
Via NewMediaWire
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
Via TheNewswire.com
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
ROSEN, A TOP RANKED LAW FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB
From The Rosen Law Firm PA
Via GlobeNewswire
Red Flag Alert: 3 Stocks That Hindenburg Research Is Shorting Now
Via InvestorPlace
RENOVARO ALERT: Bragar Eagel & Squire, P.C. is Investigating Renovaro Biosciences Inc. on Behalf of Renovaro Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
Via NewMediaWire
ROSEN, A LEADING LAW FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
Via TheNewswire.com
RENB SHAREHOLDER ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB
From The Rosen Law Firm PA
Via GlobeNewswire
Cutting Edge Blood Genetic Testing Using Nvidia AI Chips Emerging from Acquisition of Dutch Based Cyclomics; Aim to Disrupt Cancer Diagnosis and Treatment: Renovaro Biosciences Inc. (Nasdaq: RENB)
Via Get News
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace
From Renovaro Biosciences Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.